DMK PHARMACEUTICALS CORPORAT (DMKPQ)
Institutional ownership reported to the SEC as of Q2 2026, across 23 quarters.
1
Reporting holders
$0
Reported value
0.0%
Held as options
-1
Holder change
Options share is the part of reported value carried in derivative lines rather than shares. A high figure means institutions are expressing a view on this security without owning much of it.
Holders
| Filer | Value | Shares | Their book | Held | Change |
|---|---|---|---|---|---|
| Winch Advisory Services, LLC | $0 | 1 | 0.00% | new | NEW |
Quarter by quarter
Coverage begins with the quarter ending 2018-12-31. Earlier filings exist only as occasional late amendments, too sparse to describe a market, so they are not shown.
| Quarter | Holders | Value | Shares | New | Added | Trimmed | Options |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 1 | $0 | 1 | 1 | 0 | 0 | 0.0% |
| Q1 2024 | 2 | $4 | 67 | 1 | 0 | 0 | 0.0% |
| Q4 2023 | 27 | $475.2K | 569,315 | 5 | 7 | 3 | 16.1% |
| Q3 2023 | 24 | $241.1K | 240,450 | 5 | 4 | 3 | 31.3% |
| Q2 2023 | 22 | $539.5K | 114,851 | 24 | 0 | 0 | 48.8% |
| Q1 2023 | 2 | $8.6K | 0 | 0 | 0 | 0 | 100.0% |
| Q4 2022 | 2 | $63.5K | 0 | 0 | 0 | 0 | 100.0% |
| Q3 2022 | 2 | $100.0K | 0 | 0 | 0 | 0 | 100.0% |
| Q2 2022 | 3 | $306.0K | 0 | 1 | 0 | 0 | 100.0% |
| Q1 2022 | 2 | $433.0K | 0 | 1 | 0 | 0 | 100.0% |
| Q4 2021 | 3 | $447.0K | 0 | 0 | 0 | 0 | 100.0% |
| Q3 2021 | 3 | $1.9M | 0 | 2 | 0 | 0 | 100.0% |
| Q2 2021 | 2 | $1.8M | 0 | 0 | 0 | 0 | 100.0% |
| Q1 2021 | 3 | $942.0K | 0 | 2 | 0 | 0 | 100.0% |
| Q4 2020 | 3 | $392.0K | 0 | 0 | 0 | 0 | 100.0% |
| Q3 2020 | 3 | $1.4M | 0 | 2 | 0 | 0 | 100.0% |
| Q2 2020 | 1 | $339.0K | 0 | 0 | 0 | 0 | 100.0% |
| Q1 2020 | 2 | $50.0K | 0 | 0 | 0 | 0 | 100.0% |
| Q4 2019 | 3 | $246.0K | 0 | 2 | 0 | 0 | 100.0% |
| Q3 2019 | 2 | $14.0K | 0 | 1 | 0 | 0 | 100.0% |
| Q2 2019 | 2 | $115.0K | 0 | 0 | 0 | 0 | 100.0% |
| Q1 2019 | 2 | $357.0K | 0 | 0 | 0 | 0 | 100.0% |
| Q4 2018 | 2 | $491.0K | 0 | 0 | 0 | 0 | 100.0% |